Research

Primary Investigator Dr. Md. Rofiqur Rahman Co-Primary Investigator Md. Mehedi Hasan Emon Our Approach Klebsiella pneumoniae (Kpn) is an opportunistic pathogen, and the World Health Organization (WHO) has identified it as a priority target pathogen due to its role in causing enteric diseases and significant mortality worldwide, particularly among neonates. We aim to investigate the […]

Programme Lead Dr. Umme Kulsum Assistant Scientist institute for developing Science & Health initiatives (ideSHi) Our Approach This study aims to establish a robust, low-cost serological surveillance method to assess the burden of pediatric typhoid fever in Dhaka. We will conduct a prospective cohort study with 600 children under 10 years of age, using a

Primary Investigator Abu Bakar Siddik Our Approach Hepatitis E virus (HEV) remains a significant public health concern in low- and middle-income countries, including Bangladesh, where outbreaks frequently occur due to contaminated drinking water. Given the high burden of HEV and the associated complications, particularly among pregnant women, we have initiated a study to evaluate HEV

Program Lead Dr. Mohammad Tanbir Habib Communication Mahin Hasan (mahin.hasan@ideshi.org) Abstract BRCA1 and BRCA2 are tumor-suppressing genes, required by the DNA damage-repairing pathway to maintain genomic stability. Malfunctioning of the BRCA1 or BRCA2 gene via hereditary or somatic mutation can cause breast/ovarian cancer. Approximately 15% to 20% of all women with invasive ovarian cancer carry

Program Lead Dr. Kasrina Azad Our Approach There are estimated 60,000-70,000 patients are suffering from thalassemia and 2500 thalassemia major cases are added in Bangladesh every year. And, unknowingly and unwittingly they are contributing to the spread of the disease by marrying another carrier. The carriers are otherwise normal individuals without any signs or symptoms

Program Lead Abu Bakar Siddik, Anika Tahsin Our Approach Our approach delves into the multifaceted landscape of dengue fever during an outbreak in Bangladesh. We seek to understand the nuances of the disease’s clinical spectrum by describing the role of dengue serotypes (serotype-specific genotypes) and immunological parameters. To investigate the variables affecting the clinical outcomes

Program Lead Abu Bakar Siddik Our Approach Our COVID-19 research further focused on long-term effects on pulmonary function (PF) as well as serological aspects of individuals recovering from COVID-19 with varying disease severity ranging from mild to severe symptoms. We intend to evaluate their antibody responses, particularly IgG, before and after vaccination. Simultaneously, we examine

Program Lead Abu Bakar Siddik Our Approach As part of our ongoing efforts to contain the COVID-19 pandemic since it first started in 2020, we have extended our research to include the forcibly displaced Myanmar nationals (FDMN)also as known as Rohingya population in Cox’s Bazar, Bangladesh. Recognizing the unique challenges that this vulnerable community faces,